CICATRIN POWDER
CICATRIN POWDER
Discontinued
DIN Number
00666173
Drug Class
Human
Market Date
Dec 31, 1987
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00666173
AIG Number0517518001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06AX04 NEOMYCIN
Product Specifications
Dosage FormPowder
Route of AdministrationTopical
AHFS Classification84:04.04
Health Canada Classification
ACTIVE INGREDIENTS (5)
BACITRACIN ZINCActive
Strength: 250 UNIT / G
Monograph: BACITRACIN ZINC
GLYCINEActive
Strength: 10 MG / G
Monograph: GLYCINE
L-CYSTEINEActive
Strength: 2 MG / G
Monograph: L-CYSTEINE
NEOMYCIN SULFATEActive
Strength: 3300 UNIT / G
Monograph: NEOMYCIN SULFATE
THREONINEActive
Strength: 1 MG / G
Monograph: THREONINE